Hydrogen-Bonded Aryl Amide Macrocycles
Macrocycle 3: White solid. Mp >300 °C dec. 1H NMR (CDCl3)
δ 9.49 (s, 6 H), 8.32 (d, J ) 7.8 Hz, 6 H), 8.22 (s, 6 H), 7.50 (t,
J ) 7.8 Hz, 3 H), 4.06 (s, 9 H), 3.94 (s, 9 H), 2.45 (s, 9 H). 13C
NMR (CDCl3) δ 162.7, 155.2, 136.7, 136.0, 135.8, 130.8, 128.1,
126.2, 118.0, 64.6, 61.5, 21.9. MS (MALDI-TOF) m/z 959.4 [M
+ Na]+. HRMS (MALDI-FT) calcd for C51H48N6O12Na [M]+
959.3222, found 959.3259.
19F NMR (CDCl3) δ -111.3 (s, 2 F), -147.2 (s, 1 F). MS (ESI)
m/z 726.3 [M + H]+. Anal. Calcd for C39H46F3N3O7‚0.5H2O: C,
63.75; H, 6.45; N, 5.72. Found: C, 63.77; H, 6.25; N, 5.55.
1
Compound 16: H NMR (CDCl3) δ 10.40 (s, 2 H), 8.35 (d, J
) 7.8 Hz, 2 H), 8.21 (d, J ) 7.2 Hz, 2 H), 8.03-7.96 (m, 4 H),
3.57 (t, J ) 6.0 Hz, 2 H), 3.28 (t, J ) 4.5 Hz, 2 H), 1.65-1.64 (m,
4 H), 1.30-1.10 (m, 24 H), 0.85-0.75 (m, 6 H). 13C NMR (CDCl3)
δ 169.3, 165.2, 162.1, 162.0, 148.8, 147.1, 145.4, 140.8, 133.6,
128.1, 126.1, 118.9, 48.9, 44.8, 31.7, 29.0, 28.5, 27.5, 26.9, 26.3,
22.5, 14.3. 19F NMR (CDCl3) δ -137.0 (s, 1 F). MS (ESI) m/z
692 [M + H]+. HRMS (ESI) calcd for C37H47N5O7F [M]+
692.3454, found 692.3455. Anal. Calcd for C37H46FN5O7‚H2O: C,
62.61; H, 6.82; N, 9.87. Found: C, 62.25; H, 7.02; N, 9.73.
Macrocycle 4: White solid. Mp >300 °C dec. 1H NMR (CDCl3)
δ 10.79 (s, 4 H), 8.46 (d, J ) 7.5 Hz, 4 H), 8.23 (t, J ) 7.5 Hz, 2
H), 8.00 (s, 4 H), 3.65 (s, 6 H), 2.45 (s, 6 H). 13C NMR (CDCl3)
δ 160.6, 149.2, 140.4, 137.0, 136.0, 130.9, 125.1, 114.3, 61.5, 22.0.
MS (MALDI-TOF) m/z 567 [M + H]+. HRMS (MALDI-FT) calcd
for C30H27N6O6 [M]+ 567.1987, found 567.1985.
Compound 11: To a solution of 2-fluoro-3-(methoxycarbonyl)-
benzoic acid27 (1.00 g, 5.52 mmol) in THF (20 mL) were added
oxalyl dichloride (2.0 mL, 25 mmol) and DMF (0.1 mL). The
solution was stirred at room temperature for 0.5 h and then
concentrated in vacuo. The resulting pale yellow solid 10 was
dissolved in THF (30 mL). This solution was then added dropwise
to a stirred solution of 5 (1.09 g, 2.77 mmol) and triethylamine (4
mL) in THF (30 mL), which was cooled in an ice-bath. Stirring
was continued for 1 h and the solution concentrated under reduced
pressure. The resulting residue was triturated with chloroform (30
mL). After workup, the crude product was purified by column
chromatography (hexane/AcOEt 2:1 to 3:2) to afford 11 as a white
Compound 13: To a solution of 12 (0.65 g, 0.89 mmol) in THF
(20 mL) were added oxalyl dichloride (1.0 mL, 12 mmol) and DMF
(0.1 mL). The solution was stirred at room temperature for 0.5 h
and then concentrated. The resulting pale yellow solid was dissolved
in THF (30 mL) and the solution added slowly to a stirred solution
of 5a (1.65 g, 2.67 mmol) and triethylamine (2 mL) in THF (30
mL) at °C. The solution was stirred for 1 h and concentrated under
reduced pressure. The resulting residue was triturated with chlo-
roform (30 mL). After workup, the crude product was purified by
column chromatography (n-hexane/AcOEt 3:2) to afford 13 as a
pale yellow solid (0.80 g, 60%). 1H NMR (CDCl3) δ 9.15 (d, J )
4.5 Hz, 2 H), 8.85 (d, J ) 10.2 Hz, 2 H), 8.25 (d, J ) 4.8 Hz, 2
H), 8.15-8.10 (m, 4 H), 7.67 (s, 2 H), 7.37 (t, J ) 6.9 Hz, 2 H),
6.59 (d, J ) 5.4 Hz, 2 H), 3.43-3.22 (m, 12 H), 1.04-1.00 (m, 72
H), 0.89 (s, 9 H), 0.82 (s, 9 H). 13C NMR (CDCl3) δ 170.9, 170.1,
161.3, 160.9, 159.5, 156.1, 144.0, 140.8, 135.1, 134.9, 133.5, 133.3,
126.2, 126.1, 125.9, 125.7, 125.1, 123.1, 123.0, 122.8, 116.5, 111.3,
109.8, 60.4, 49.5, 49.2, 45.3, 45.0, 31.8, 31.7, 29.7, 29.4, 29.3, 29.1,
28.6, 27.4, 27.1, 26.6, 22.7, 22.6, 21.0, 14.1. 19F NMR (CDCl3) δ
-114.2 (s, 2 F), -142.7 (s, 1 F), -150.1 (s, 2 F). MS (MALDI-
TOF) m/z 1499.0 [M + Na]+. HRMS (MALDI-TOF) calcd for
C85H123N9O7F5 [M]+ 1476.9460, found 1476.9483.
By using a similar procedure, compound 17 was prepared from
16 and 5 (4 equiv) as a white solid in 60% yield. 1H NMR (CDCl3)
δ 10.00 (s, 2 H), 9.79 (s, 2 H), 8.46 (d, J ) 7.2 Hz, 2 H), 8.41 (d,
J ) 8.1 Hz, 4 H), 8.08 (t, J ) 7.8 Hz, 2 H), 7.71 (d, J ) 5.4 Hz,
2 H), 6.43 (d, J ) 7.2 Hz, 2 H), 3.79 (s, 4 H), 3.34 (s, 6 H), 3.19
(s, 6 H), 1.65-1.50 (m, 12 H), 1.42-1.21 (m, 36 H), 1.18-1.01
(m, 18 H). 13C NMR (CDCl3) δ 175.1, 171.2, 170.0, 161.0, 160.9,
148.9, 148.3, 143.6, 140.5, 139.7, 135.8, 135.7, 134.0, 133.6, 125.9,
125.7, 125.5, 125.3, 114.9, 111.9, 107.9, 49.4, 45.3, 45.1, 31.9,
31.8, 30.7, 29.7, 29.6, 29.5, 29.3, 29.1, 28.7, 27.7, 27.2, 26.7, 22.7,
22.6, 17.7, 14.1. 19F NMR (CDCl3) δ -148.7 (s, 1 F), -153.8 (t,
J ) 33.0 Hz, 2 F). MS (MALDI-FT) m/z 1443.5 [M + H]+. HRMS
(MALDI-TOF) calcd for C83H123N11O7F3 [M]+ 1442.9535, found
1442.9547.
1
solid (1.45 g, 70%). H NMR (CDCl3) δ 8.83 (d, J ) 16.2 Hz, 2
H), 8.33 (t, J ) 7.5 Hz, 2 H), 8.26 (d, J ) 6.6 Hz, 2 H), 8.13 (t,
J ) 7.2 Hz, 2 H), 3.99 (t, J ) 0.9 Hz, 6 H), 3.44 (s, 2 H), 3.24 (s,
2 H), 1.34-1.18 (m, 20 H), 0.88 (s, 3 H), 0.79 (s, 3 H). 13C NMR
(CDCl3) δ 169.9, 164.0, 164.0, 161.2, 160.7, 157.7, 136.7, 136.2,
133.9, 133.8, 126.1, 125.9, 124.8, 124.7, 122.4, 122.2, 119.8, 119.7,
116.3, 53.0, 52.8, 52.5, 49.4, 45.3, 31.8, 31.7, 31.6, 29.4, 29.3, 29.1,
28.7, 27.5, 27.2, 26.7, 22.7, 22.6, 14.1, 14.0. 19F NMR (CDCl3)
δ -112.1 (d, t, J1 ) 16.8 Hz, J2 ) 6 Hz, 2 F), -144.2 (s, 1 F).
MS (MALDI-TOF) m/z 754.5 [M + H]+. Anal. Calcd for
C41H50F3N3O7: C, 65.32; H, 6.69; N, 5.57. Found: C, 65.55; H,
6.79; N, 5.46.
By using a similar procedure, compound 15 was prepared in 65%
yield as white solid from 5a and 14.28 1H NMR (CDCl3) δ 10.36
(s, 2 H), 8.47 (d, J ) 8.1 Hz, 2 H), 8.36-8.30 (m, 4 H), 8.10 (t,
J ) 7.8 Hz, 2 H), 4.07 (s, 6 H), 3.48 (t, J ) 7.8 Hz, 2 H), 3.27 (t,
J ) 7.8 Hz, 2 H), 1.67-1.59 (m, 4 H), 1.37-1.12 (m, 20 H), 0.88
(t, J ) 6.6 Hz, 6 H). 13C NMR (CDCl3) δ 170.0, 164.7, 161.3,
149.5, 146.8, 145.6, 142.3, 139.0, 134.1, 134.0, 127.8, 126.1, 126.0,
125.6, 115.4, 53.1, 49.4, 45.3, 31.8, 29.4, 29.3, 29.1, 28.7, 27.6,
27.2, 26.7, 22.7, 14.1, 1.0. 19F NMR (CDCl3) δ -144.1 (s, 1 F).
MS (ESI) m/z 720.3 [M + H]+. Anal. Calcd for C39H50FN5O7: C,
65.07; H, 7.00; N, 9.73. Found: C, 65.05; H, 7.02; N, 9.63.
Compound 12: A solution of 11 (1.25 g, 1.66 mmol) and lithium
hydroxide (0.24 g, 10.0 mmol) in water (50 mL) and THF (10 mL)
was stirred at room temperature for 2 h. Hydrochloric acid (2 N)
was added dropwise to pH 5 and then the mixture was concentrated
under reduced pressure. The resulting residue was suspended in
water (5 mL). The precipitate formed was filtered, washed with
water, and recrystallized from ethanol to give 12 as a white solid
Acknowledgment. This work was financially supported by
the National Natural Science Foundation (Nos. 20732007,
20425208, 20572126, 20621062, 20672137) and the National
Basic Research Program (2007CB808000) of China.
1
(1.14 g, 95%). H NMR (CDCl3) δ 8.94 (d, J ) 20.4 Hz, 2 H),
8.47-8.42 (m, 4 H), 8.24 (t, J ) 7.5 Hz, 2 H), 7.40 (t, J ) 7.5 Hz,
2 H), 3.49 (s, 2 H), 3.27 (s, 2 H), 1.38-1.19 (m, 24 H), 0.92 (s, 3
H), 0.78 (s, 3 H). 13C NMR (DMSO-d6) δ 168.9, 164.6, 162.6,
159.1, 157.0, 134.1, 132.7, 128.9, 128.2, 125.9, 125.4, 124.4, 120.2,
119.0, 48.6, 44.4, 31.2, 28.6, 28.5, 28.1, 27.0, 26.4, 25.9, 22.0, 13.9.
Supporting Information Available: General experimental
procedures, UV-vis and fluorescent spectra of partial complexes,
the simulated diffusion decay curves of 1, 1 + C60, and 1 + C70,
1H NMR spectra of new compounds, and CIF files of 3, 4, and 15.
This material is available free of charge via the Internet at
(27) Wang, Q.-C.; Qu, D.-H.; Ren, J.; Chen, K.; Tian, H. Angew. Chem.,
Int. Ed. 2004, 43, 2661.
(28) Wang, X.-B.; Dacres, J. E.; Yang, X.; Broadus, K. M.; Lis, L.; Wang,
L.-S.; Kass, S. R. J. Am. Chem. Soc. 2003, 125, 296.
JO702046F
J. Org. Chem, Vol. 73, No. 5, 2008 1751